Business Context and Reporting Period
This Form 8-K was filed by Compass Diversified Holdings and Compass Group Diversified Holdings LLC on September 26, 2016, reporting events that occurred on September 21 and September 22, 2016. The filing discloses the consummation of a merger agreement regarding the sale of a majority-owned subsidiary.
Key Financial Metrics
- Transaction Value: Total enterprise value of $25 million for the sale of Tridien Medical.
- Proceeds Received: Approximately $21 million received by CODI at closing after allocating the sales price to non-controlling equityholders and paying transaction expenses.
- Use of Proceeds: Funds will be used to pay down outstanding debt under Tridien's revolving credit facility with CODI.
- Impact on Earnings: CODI does not expect to record a significant gain or loss from the sale.
Material Changes
The primary material change is the divestiture of Anodyne Medical Device, Inc. (d/b/a Tridien Medical), which was acquired by CODI on August 1, 2006. Following the transaction, Tridien became a wholly owned subsidiary of Hill-Rom Holdings, Inc. This represents a reduction in CODI's portfolio of operating companies.
Outlook and Management Commentary
Management indicated that the transaction was executed via a definitive agreement and plan of merger with a wholly owned subsidiary of Hill-Rom Holdings, Inc. The filing notes that the proceeds address specific debt obligations related to the subsidiary. No forward-looking guidance regarding future revenue or earnings was provided in this specific filing.
Investor Verification Checklist
- Verify the exact allocation of the $25 million enterprise value between CODI and non-controlling equityholders.
- Confirm the specific amount of debt under the Tridien revolving credit facility that was retired with the $21 million proceeds.
- Review the attached press release (Exhibit 99.1) for details on the treatment of accrued interest and fees.
- Assess the impact of this divestiture on CODI's overall portfolio concentration and future cash flow projections.